----

----

| Delaware                                                       |   | 13-3419202                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (I.R.S. Employer Identification No.) |

| Large accelerated filer     ̈                                                  |   | Accelerated filer     ̈     |
|--------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------|
| Non-accelerated filer       ̈ (Do not check if smaller reporting company) |   | Smaller Reporting Company     x |

----

----

|                                                                                                    | Page   |
|---------------------------------------------------------------------------------------------------------|--------|
|                                                                                                    |   |
| EXPLANATORY NOTE                                                                                        | 1      |
| PART III                                                                                                | 3      |
| ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE                                         | 3      |
| ITEM 11. EXECUTIVE COMPENSATION                                                                         | 6      |
| ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS | 9      |
| ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE                      | 13     |
| ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES                                                         | 14     |
| PART IV                                                                                                 | 14     |
| ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES                                                     | 14     |
| SIGNATURES                                                                                              | 15     |
| EXHIBIT INDEX                                                                                           | 16     |

----

| Name                     |   | Age |   | Position                                        |
|--------------------------|--------|-----|--------|-------------------------------------------------|
| Brian E. Stewart         |   | 41  |   | Director, President and Chief Executive Officer |
| David C. Dreyer          |   | 55  |   | Chief Financial Officer and Secretary           |
| John P. Francis          |   | 47  |   | Director                                        |
| Louis Glazer, M.D. Ph.G. |   | 81  |   | Director                                        |
| Lynne Silverstein        |   | 42  |   | Director                                        |
| Wenchen Lin              |   | 58  |   | Director                                        |

----

----

----

| Name andprincipal position            |   |   |   Year   |   | Salary($) |    |   | Bonus($) |   |    | WarrantAndStock option Awards($)(1) |   |   | Non-equityIncentivePlanCompensation($) |   |   | Non-qualifieddeferredcompensationearnings ($) |    |   | All othercompensation($)(2) |   |    | Total  |   |
|-------------------------------------------------|--------|--------|---------------|--------|-----------|---------|--------|----------|--------|---------|------------------------------------------|--------|--------|----------------------------------------|--------|--------|----------------------------------------------------|---------|--------|----------------------------------|--------|---------|--------|--------|
| Brian E. Stewart                                |   |   | 2012          |   | $         | 240,000 |   |     |   | 84,000  |                                     |   | $      | 88,290                                 |   |   |                                               | — |   |                             |   | — |   |   | $ | 23,482 |   |   | $ | 435,772 |   |
| President, Chief ExecutiveOfficer and director  |   |   | 2011          |   | $         | 200,000 |   |     |   | — |                                     |   | $      | 7,560                                  |   |   |                                               | — |   |                             |   | — |   |   | $ | 21,778 |   |   | $ | 229,338 |   |
|                                            |   |   |     |   |      |    |   |     |   |    |                                     |   |   |                                   |   |   |                                               |    |   |                             |   |    |   |   |   |   |   |   |   |   |   |
| David Dreyer                                    |   |   | 2012          |   | $         | 240,000 |   |     |   | 60,000  |                                     |   |   | 88,290                                 |   |   |                                               | — |   |                             |   | — |   |   | $ | 23,482 |   |   | $ | 411,772 |   |
| Chief Financial Officer,Treasurer and Secretary |   |   | 2011          |   | $         | 200,000 |   |     |   | — |                                     |   | $      | —                                |   |   |                                               | — |   |                             |   | — |   |   |   | 19,569 |   |   | $ | 219,569 |   |

----

----

| Warrant and Option Awards |
|------------------------------------------|
|                                     |   | Number of |   |   | Number of |   |   |   |   |   |   |
|                                     |   | Securities |   |   | Securities |   |   | Option or |   |   |   |
|                                     |   | Underlying |   |   | Underlying |   |   | Warrant |   |   |   |
|                                     |   | Unexercised |   |   | Unexercised |   |   | Weighted |   |   |   |
|                                     |   | Options or |   |   | Options or |   |   | Average |   |   |   |
|                                     |   | Warrants |   |   | Warrants |   |   | Exercise |   |   | Option or Warrant |
| Name                                     |   | Exercisable |   |   | Unexercisable |   |   | Price |   |   | expiration date |
|                                     |   |   |   |   |   |   |   |   |   |   |   |
| Brian E. Stewart (1)                     |   |   | 1,464,286 |   |   |   | 535,714 |   |   | $ |       0.80 |   |   | 11/15/2020 |
| Director, President and                  |   |   | 198,560 |   |   |   | -  |   |   | $ |           1.09 |   |   | 07/31/2013 |
| Chief Executive Officer                  |   |   | - |   |   |   | 100,000 |   |   | $ |       1.20 |   |   | 1/30/2022 |
|                                     |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| David Dreyer (2)                         |   |   | 259,028 |   |   |   | 190,972 |   |   | $ |       0.75 |   |   | 10/22/2020 |
| Chief Financial Officer,                 |   |   | - |   |   |   | 100,000 |   |   | $ |       1.20 |   |   | 1/30/2022 |
| Treasurer and Secretary                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

| (1) | Mr. Stewart received a stock option grant for a total of 2,000,000 shares of our common stock, 500,000 of which vested as of the date of the grant and 250,000 of which vested and became exercisable on December 22, 2010. The unvested options vest at a rate of approximately 29,762 shares monthly, with 100% of the option becoming exercisable on November 15, 2014. The 198,560 shares relate to warrants to purchase shares of our common stock. In January of 2012 Mr. Stewart received a stock option grant for 100,000 shares of our common stock, of which 25% vested after the first year and the remaining vested monthly over the remaining 36 months. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Mr. Dreyer received a stock option grant for 450,000 shares of our common stock, of which 100,000 vested on April 22, 2011.  The unvested options vest at a rate of approximately 8,333 shares monthly, with 100% of the option becoming exercisable on October 22, 2014. In January of 2012 Mr. Dreyer received a stock option grant for 100,000 shares of our common stock, of which 25% vested after the first year and the remaining vested monthly over the remaining 36 months. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| Name                  |   Expiration Date |   |  Option ExercisePrice |   | Shares |    |
|-----------------------|------------------------|--------|----------------------------|--------|--------|---------|
| John P. Francis       |                   |   |                       |   |   | — |   |
| Louis Glazer, MD, PhG |   3/30/2015       |   |  5.27                 |   |   | 90,000  |   |
| Lynne Silverstein     |                   |   |                       |   |   | — |   |
| Wenchen Lin           |   1/25/2016       |   |  4.10                 |   |   | 90,000  |   |

| Shares Beneficially Owned (b)                                                                                                                  |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                                     |   | Common Stock |   |   | Series A Preferred Stock |   |
| Name and Address of Beneficial Owner (a)                                                                                        |   | Number of Shares |   |   | % |   |   | Number of Shares |   |   | % |   |
| Kinderhook Partners, LP2 Executive DrSuite 585Fort Lee, NJ 07024                                                                                         |   |   | 7,359,435 | (c) |   |   | 20 | % |   |   | — |   |   |   | * |   |
| Francis Capital Management, LLC1453 Third St. , Suite 470Santa Monica, CA 90401                                                                               |   |   | 3,206,840 | (d) |   |   | 9 | % |   |   | — |   |   |   | * |   |
| Compass Global Management, Ltd.c/o M&C Corporate Services limitedP.O. Box 309 GT, Ugland HouseSouth Church Street, GeorgetownGrand Cayman, Cayman Islands |   |   | 2,600,000 | (e) |   |   | 7 | % |   |   | — |   |   |   | * |   |
| Cardinal Health, Inc.7000 Cardinal PlaceDublin, OH 43017                                                                                                      |   |   | 1,875,000 | (f) |   |   | 5 | % |   |   | — |   |   |   | * |   |
| Catalysis Partners, LLC1453 Third St. , Suite 470Santa Monica, CA 90401                                                                                       |   |   | 1,488,864 | (d) |   |   | 4 | % |   |   | — |   |   |   | * |   |
| Radisson Trading CompanyRM 1502-4, Righteous Centre585 Nathan Road, Mongkok,Kowloon, Hong Kong                                                                |   |   | 3,029,333 | (g) |   |   | 8 | % |   |   | — |   |   |   | * |   |
| Catalysis Offshore, Ltd.1453 Third St. , Suite 470Santa Monica, CA 90401                                                                                      |   |   | 1,565,336 | (d) |   |   | 4 | % |   |   | — |   |   |   | * |   |
| Melanie Glazer2100 South Ocean Lane #2408Ft Lauderdale, FL 33316                                                                                              |   |   | 753,184 | (h) |   |   | 2 | % |   |   | 10,750 |   |   |   | 98 | % |
| Brian Stewart                                                                                                                                                 |   |   | 2,574,989 | (i) |   |   | 6 | % |   |   | — |   |   |   | * |   |
| John P. Francis                                                                                                                                               |   |   | 3,206,840 | (j) |   |   | 9 | % |   |   | — |   |   |   | * |   |
| Louis Glazer, MD                                                                                                                                              |   |   | 753,184 | (k) |   |   | 2 | % |   |   | 10,750 |   |   |   | 98 | % |
| Lynne Silverstein                                                                                                                                             |   |   | 91,330 |   |   |   | * |   |   |   | — |   |   |   | * |   |
| Wenchen Lin                                                                                                                                                   |   |   | 1,100,000 | (l) |   |   | 3 | % |   |   | — |   |   |   | * |   |
| David Dreyer                                                                                                                                                  |   |   | 540,764 | (m) |   |   | * |   |   |   | — |   |   |   |   |   |
| All named directors and executive officers as a group (6 persons total)                                                                                       |   |   | 8,267,107 | (n) |   |   | 21 | % |   |   | 10,750 |   |   |   | 98 | % |

----

| (a) The address of each person named in the table, unless otherwise indicated, is c/o Patient Safety Technologies, Inc., 2 Venture Plaza, Suite 350 Irvine CA, 92618.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (b) To our knowledge, the persons named in the table have sole voting and investment power with respect to all shares of our common stock and/or preferred stock shown as beneficially owned by them, subject to community property laws where applicable (or other beneficial ownership shared with a spouse) and the information contained in this table and these notes. The Series A Stock votes on all matters submitted to our stockholders for a vote, voting together with the holders of our common stock as a single class, with each share of Series A Stock entitled to one vote per share. Except in special circumstances and where mandated by law, our Series B Convertible Preferred Stock (the "Series B Stock") is non-voting. Beneficial ownership has been determined in accordance with SEC rules, which generally attribute beneficial ownership of securities to each person who possesses, either solely or shared with others, the power to vote or dispose of those securities. SEC rules also treat as beneficially owned all shares that a person would receive upon exercise or conversion of stock options, warrants or other securities or rights held by that person that are immediately exercisable or convertible, or exercisable or convertible within 60 days of the determination date, which in our case is March 31, 2013. Such shares are deemed to be outstanding for the purpose of computing the number of shares beneficially owned and the percentage ownership of the person holding such options, warrants securities or other rights, but these shares are not treated as outstanding for the purpose of computing the percentage ownership of any other person. On March 31, 2013, there were 37,543,448 shares of our common stock issued and outstanding and 10,950 shares of our Series A Stock issued and outstanding. Subject to the terms and conditions of our Series B Stock and to customary adjustments to the conversion rate, each share of our Series B Stock is convertible into 133 shares of our common stock so long as the number of shares of our common stock "beneficially owned" (as defined in Rule 13d-3(d)(i) under the Securities Exchange Act of 1934, as amended) by the holder, its affiliates and any persons acting as a group with such holder or its affiliates, following such conversion, does not exceed 4.9% of our outstanding common stock (after giving effect to such conversion) (the "Beneficial Ownership Limitation"). Holders of our Series B Stock may, upon not less than 61 days' prior notice, increase or decrease the Beneficial Ownership Limitation provided that such Beneficial Ownership Limitation in no event exceeds 9.9% of the shares of common stock outstanding immediately after giving effect to such conversion. Therefore, under SEC rules, a holder who only owns Series B Stock would generally not be deemed a 5% holder because such shares cannot be converted within 60 days of the determination date. Accordingly, such a holder would not be disclosed on this table as a 5% holder. However, for holders of Series B Stock for whom disclosure is required on this table for reasons other than 5% ownership of Series B Stock (i.e., directors and executive officers), the shares underlying the Series B Stock they hold, if any, up to the 4.9% Beneficial Ownership Limit, would be included in the ownership information in this table, unless such limit would preclude any conversion of such Series B Stock. |

----

| (c) Information is based on a Form 4 filed on May 21, 2012 by Kinderhook Partners, LP. Kinderhook Capital Management, LLC serves as the investment adviser to Kinderhook Partners, LP (the "Partnership"). Kinderhook GP, LLC serves as the general partner (the "General Partner") to the Partnership, and Messrs. Tushar Shah and Stephen Clearman serve as the General Partner's managing members, responsible for making investment decisions with respect to the Partnership and, as a result, Mr. Shah and Mr. Clearman may be deemed to control such entities. In addition, Mr. Shah and Mr. Clearman are responsible for making investment decisions with respect to Kinderhook Capital Management, LLC. Accordingly, Mr. Shah and Mr. Clearman may be deemed to have a beneficial interest in the shares of Common Stock by virtue of their indirect control of the Partnership's, the General Partner's and Kinderhook Capital Management, LLC's power to vote and/or dispose of the shares of Common Stock. Mr. Shah and Mr. Clearman disclaim beneficial ownership of the shares of Common Stock except to the extent of his respective pecuniary interest, if any, therein. Kinderhook Capital Management, LLC specifically disclaims beneficial ownership in the shares of Common Stock reported herein except to the extent of its pecuniary interest therein, if any. |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (d) Information is based on a Form 4 filed on February 5, 2013 by John Francis. John Francis is the managing member of Francis Capital Management, LLC, a California limited liability company ("FCM"), which is the managing member of Catalyis LLC and the investment manager of Catalysis Ltd. John Francis has sole voting and dispositive power over Shares held by Catalysis LLC and Catalysis Ltd. Ownership is 152,640 Shares held by FCM, 1,488,864 Shares held by Catalysis LLC, and 1,565,336 Shares held by Catalysis Ltd. of which John Francis has sole voting and dispositive power but disclaims beneficial ownership except to the extent of his pecuniary interest therein. The inclusion of disclaimed Shares in this Report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. Excludes 11,628 shares of our Series B Stock owned by Catalysis. See footnote (b).                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (e) Information is based on a Schedule 13D filed on April 16, 2010. Includes warrants to acquire 1,000,000 shares of our common stock at an exercise price of $1.40 per share, which expire August 1, 2013.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (f) Includes warrants to purchase 1,250,000 shares of the our common stock at an exercise price of $2.00 per share and warrants to purchase 625,000 shares of our common stock at an exercise price of $4.00 per share. The warrants expire November 19, 2014.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (g) Information is based on a Schedule 13D filed on April 16, 2010 and our knowledge of the issuance in March 2011 of 1,333,333 shares of common stock to Radisson Trading Company.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (h) Common stock includes (i) 226,991 shares of common stock held in various trusts for the benefit of Mrs. Glazer, (ii) 339,593 shares of common stock held in the Glazer Family Partnership, over which Mrs. Glazer shares control with her husband, Dr. Glazer, (iii) 6,600 shares held by Dr. Glazer, (iv) options to purchase 180,000 shares of our common stock held by Dr. Glazer. Series A Stock includes (i) 1,500 shares of Series A Stock held in various trusts for the benefit of Mrs. Glazer, (ii) 6,650 shares of Series A Stock held in the Glazer Family Partnership over which Mrs. Glazer shares control with her husband, Dr. Glazer and (iii) 2,600 shares of Series A Stock held by both Dr. Glazer and Mrs. Glazer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (i) Includes (i) 730,000 shares of our common stock, (ii) warrants to acquire 98,560 shares of our common stock at an exercise price of $0.75 per share, which expire May 20, 2013, (iii) warrants to acquire 100,000 shares of our common stock at an exercise price of $1.40 per share, which expire August 1, 2013, and (iv) options to purchase 1,646,429 shares of our common stock exercisable within 60 days of March 31, 2013.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (j) Information is based on a Form 4 filed on February 5, 2013. Represents securities beneficially owned by Francis Capital Management, LLC. Mr. Francis has voting and investment control over securities held by Francis Capital Management, LLC. Mr. Francis disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (k) Common stock includes (i) 198,971 shares of common stock held in various trusts for the benefit of Melanie Glazer, Dr. Glazer's spouse, (ii) 28,020 shares held by Mrs. Glazer, (iii) 339,593 shares of common stock held in the Glazer Family Partnership, over which Dr. Glazer shares control with his spouse and (iv) options to purchase 180,000 shares of our common stock held by Dr. Glazer. Series A Stock includes (i) shares of Series A Stock held in various trusts for the benefit of Mrs. Glazer, (ii) shares of Series A Stock held in the Glazer Family Partnership over which Dr. Glazer shares control with his spouse and (iii) 2,600 shares of Series A Stock held by both Dr. Glazer and Mrs. Glazer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (l) Includes 1,100,00 shares of common stock held by A Plus International Inc., which information is based on a Schedule 13D filed on April 16, 2010, but excludes 11,628 shares of our Series B Stock owned by A Plus (see footnote (b)). Mr. Lin may be deemed the beneficial owner of the shares held by A Plus by virtue of his managerial control of A Plus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (m) Includes (i) 205,000 shares of our common stock and (ii) options to purchase 335,764 shares of our common stock exercisable within 60 days of March 31, 2013.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| (n) Includes 5,906,354 shares of common stock, options to purchase 2,162,193 shares of our common stock exercisable within 60 days of March 31, 2013, and warrants to purchase 198,560 shares of our common stock.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

----

| As of December 31, 2012            |   |
|--------------------------------------------------------|--------|
|                                              |   | Number of Securitiestobe Issued uponExerciseof OutstandingOptions |   |   | Weighted AverageExercise Price ofOutstandingOptions |   |   | Number of SecuritiesRemaining Available forFuture Issuance UnderEquity CompensationPlans (ExcludingSecurities Reflected inColumn (a) |   |
| Plan Category                                     |   | Column (a) |   |   | Column (b) |   |   | Column (c) |   |
|                                                   |   |   |   |   |   |   |   |   |   |   |   |   |
| Equity compensation plans approved by stockholders     |   |   | 3,718,901 | (1) |   | $ | 1.32 | (2) |   |   | 3,281,099 | (3) |
| Equity compensation plans not approved by stockholders |   |   | 1,878,334 |   |   | $ | 0.86 |   |   |   | — |   |
| Total:                                                 |   |   | 5,597,235 |   |   | $ | 1.19 |   |   |   | 3,281,099 |   |

----

----

|                                     |   | 2011   |    |   | 2012   |   |
|------------------------------------------|--------|--------|---------|--------|--------|--------|
| Audit Fees                               |   | $      | 140,616 |   |   | $      | 142,560 |   |
| Audit-related Fees                       |   | $      | 46,006  |   |   | $      | 21,332 |   |
| Tax Fees                                 |   |   | 3,081   |   |   |   | — |   |
|      Total Fees |   | $      | 189,703 |   |   | $      | 163,892 |   |

----

|   | PATIENT SAFETY TECHNOLOGIES, INC. |
|--------|-----------------------------------|
|   |                              |   |
|   | By:                               | /S/ BRIAN E. STEWART |
|   |                              | Brian E. Stewart |
|   |                              | President and Chief Executive Officer |

----

| ExhibitNumber |   | Description                                                                                                                                                                                                |
|---------------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          |   |                                                                                                                                                                                                       |
| 3.1.1         |   | Certificate of Amendment of Amended and Restated Certificate of Incorporation (incorporated by reference to Annex A to our definitive proxy statement on Schedule 14A filed with the SEC on June 27, 2012) |
|          |   |                                                                                                                                                                                                       |
| 31.1          |   | Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15D-14(a)                                                                                                                      |
|          |   |                                                                                                                                                                                                       |
| 31.2          |   | Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15D-14(a)                                                                                                                      |

----